SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001321543-05-000013
Filing Date
2005-06-17
Accepted
2005-06-17 09:27:26
Documents
1
Period of Report
2005-06-16

Document Format Files

Seq Description Document Type Size
1 form4-jacob_ex.html 4  
1 form4-jacob_ex.xml 4 2960
  Complete submission text file 0001321543-05-000013.txt   4877
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Issuer) CIK: 0001142380 (see all company filings)

IRS No.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O CALLISTO PHARMACEUTICALS INC 420 LEXINGTON AVE STE 2500 NEW YORK NY 10170 2122970010
JACOB GARY S (Reporting) CIK: 0001266802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32325 | Film No.: 05901546